Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE1A | P54750 | 7/20 | 0.41 |
| ▸ | PDE1B | Q01064 | 7/20 | 0.41 |
| ▸ | PDE1C | Q14123 | 7/20 | 0.41 |
| ▸ | PDE2A | O00408 | 6/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | PARG | Q86W56 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9608310 | 0.94 | PDE1B (0.41) | PDE1APDE1BPDE1CPDE2AADRA2A | |
| SCHEMBL2455942 | 0.91 | PDE1B (0.48) | PDE1APDE1BPDE1CPDE2AADRA2A | |
| SCHEMBL13334360 | 0.89 | LMNA (0.38) | PDE1BPDE2AKMT2ATRPA1PARG | |
| SCHEMBL9608307 | 0.85 | PDE1B (0.48) | PDE1APDE1BPDE1CPDE2ASLC16A1 | |
| SCHEMBL16378553 | 0.83 | PDE4A (0.38) | PDE1APDE1BPDE1CPDE2AADRA2A | |
| SCHEMBL9608344 | 0.83 | MAPT (0.34) | PDE1BPDE2AKMT2ATRPA1PARG | |
| SCHEMBL13334441 | 0.82 | PDE1A (0.41) | PDE1APDE1BPDE1CPDE2AADRA2A | |
| SCHEMBL17656455 | 0.81 | KMT2A (0.38) | ADRA2AKMT2AP2RX3ALDH1A1LMNA | |
| SCHEMBL9608334 | 0.80 | PDE1B (0.52) | PDE1APDE1BPDE1CPDE2ASLC16A1 | |
| SCHEMBL2454720 | 0.78 | PDE1B (0.50) | PDE1APDE1BPDE1CPDE2ASLC16A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367428-B1 | ORGANIC COMPOUNDS | INTRA CELLULAR THERAPIES INC (US) | 2016-04-06 | — | — | EP | disclosed |
| US-20150353556-A1 | ORGANIC COMPOUNDS | LI PENG (US) | 2015-12-10 | — | — | US | disclosed |
| US-8927556-B2 | 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds | INTRA-CELLULAR THERAPIES, INC. (US) | 2015-01-06 | — | — | US | disclosed |
| WO-2010065147-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353556-A1 | ORGANIC COMPOUNDS | CYP2C9, TPMT, CYP2C19 | PDE1A 4874/4885PDE1B 4863/4885PDE1C 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.